On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Acousia Therapeutics GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€607k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- OTOSTEMPartner
Human stem cell applications for the treatment of hearing loss
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€607ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Uppsala UniversitetSweden · 1 shared project
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- The University of SheffieldUnited Kingdom · 1 shared project
- Universitaet BernSwitzerland · 1 shared project
- Universite D'Aix MarseilleFrance · 1 shared project
- Board of Trustees of the Leland Stanford Junior UniversityUnited States · 1 shared project
- Sciprom SARLSwitzerland · 1 shared project
- Audion Therapeutics BVNetherlands · 1 shared project
- Massachusetts Eye and Ear InfirmaryUnited States · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cell biology
- drug discovery
- stem cells
- transplantation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.